Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3961 AL 3975

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND.

Alzheimers Res Ther. 2018 Oct 12;10(1):107. doi: 10.1186/s13195-018-0431-6.

The Mechanisms of Dietary Phytoestrogen as a Potential Treatment and Prevention Agent against Alzheimer's Disease

Hussain A, Tabrez ES, Muhammad A, Peela JR.

Crit Rev Eukaryot Gene Expr. 2018;28(4):321-327. doi: 10.1615/CritRevEukaryotGeneExpr.2018025847.

Effect of Exercise on Drug-Related Falls Among Persons with Alzheimer's Disease: A Secondary Analysis of the FINALEX Study

Perttila NM, Öhman H, Strandberg TE, Kautiainen H, Raivio M, Laakkonen ML, Savikko N, Tilvis RS, Pitkälä KH.

Drugs Aging. 2018 Nov;35(11):1017-1023. doi: 10.1007/s40266-018-0594-7.

Alzheimer's Disease, time to turn the tide

Sensi SL.

Aging (Albany NY). 2018 Oct 13;10(10):2537-2538. doi: 10.18632/aging.101581.

Copper-64: a real theranostic agent

Gutfilen B, Souza SA, Valentini G.

Drug Des Devel Ther. 2018 Oct 2;12:3235-3245. doi: 10.2147/DDDT.S170879. eCollection 2018.

Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients

Zhang N, Gordon ML.

Clin Interv Aging. 2018 Oct 11;13:1963-1970. doi: 10.2147/CIA.S159920. eCollection 2018.

Essential Oils as Treatment Strategy for Alzheimer's Disease: Current and Future Perspectives

Benny A, Thomas J.

Planta Med. 2019 Feb;85(3):239-248. doi: 10.1055/a-0758-0188. Epub 2018 Oct 25.

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease

Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H.

Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24.

Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study

Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen AM.

J Am Heart Assoc. 2018 Sep 18;7(18):e009742. doi: 10.1161/JAHA.118.009742.

Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology

Uddin MS, Al Mamun A, Kabir MT, Jakaria M, Mathew B, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Jul;56(7):4925-4944. doi: 10.1007/s12035-018-1420-2. Epub 2018 Nov 9.

Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review

Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y.

Clin Interv Aging. 2018 Oct 18;13:2061-2073. doi: 10.2147/CIA.S184968. eCollection 2018.

Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease

Silva CFM, Pinto DCGA, Silva AMS.

Expert Opin Drug Discov. 2018 Dec;13(12):1141-1151. doi: 10.1080/17460441.2018.1543267. Epub 2018 Nov 15.

Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease

Morsy A, Trippier PC.

J Med Chem. 2019 May 9;62(9):4252-4264. doi: 10.1021/acs.jmedchem.8b01530. Epub 2018 Nov 30.

Geroneuroprotectors: Effective Geroprotectors for the Brain

Schubert D, Currais A, Goldberg J, Finley K, Petrascheck M, Maher P.

Trends Pharmacol Sci. 2018 Dec;39(12):1004-1007. doi: 10.1016/j.tips.2018.09.008. Epub 2018 Nov 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias